Clinical Trial Update: Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating FB825 for efficacy and safety in adults with allergic asthma, and recruitment is currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• FB825 (FB825)

Snippet

Sponsor: Oneness Biotech Co., Ltd. | Conditions: Allergic Asthma | Phase 2 | Status: RECRUITING